Moleculin Biotech, Inc. (NASDAQ:MBRX) Q4 2023 Earnings Call Transcript March 25, 2024
Moleculin Biotech, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Greetings, welcome to the Moleculin Biotech 2023 Year-End Conference Call and Webcast. [Operator Instructions] Please note, that this conference is being recorded. I’d now turn the conference over to Jenene Thomas, Investor Relations. Thank you. You may...
